Sign In
Buy HAE
$65.88
-0.490 (-0.738%)
At Close: Jun 03, 2026
Haemonetics (HAE) Up 3.2% Since Last Earnings Report: Can It Continue?
03:30pm, Friday, 09'th Sep 2022 Zacks Investment Research
Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Haemonetics (HAE) Up 3.2% Since Last Earnings Report: Can It Continue?
12:48pm, Friday, 09'th Sep 2022
Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock?
Medical Device Maker Announces New Patients, Shoots Past Buy Point
03:37pm, Thursday, 08'th Sep 2022
Axonics is breaking out from a three-weeks-tight pattern after announcing it has begin treating patients in Canada. The post Medical Device Maker Announces New Patients, Shoots Past Buy Point appeared
Haemonetics: Plasma Thesis Continues To Play Out, Reiterate Buy
08:06am, Tuesday, 06'th Sep 2022
We reiterate the buy thesis on Haemonetics Corp. Strong Q2 earnings alongside healthy plasma collection market fundamentals are appealing factors.
Here's Why You Should Retain Haemonetics (HAE) Stock Now
04:40pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Investors are optimistic about Haemonetics' (HAE) better-than-expected results and strong Plasma sales.
Haemonetics (HAE) Business Recovery Continues, Macro Issues Ail
04:36pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Despite sluggish results of Haemonetics' (HAE) Blood Center business, Whole Blood revenues grow on favorable order timing among distributors in the Asia Pacific and EMEA.
Haemonetics (HAE) Business Recovery Continues, Macro Issues Ail
02:17pm, Friday, 02'nd Sep 2022
Despite sluggish results of Haemonetics' (HAE) Blood Center business, Whole Blood revenues grow on favorable order timing among distributors in the Asia Pacific and EMEA.
Here's Why You Should Retain Haemonetics (HAE) Stock Now
02:17pm, Friday, 02'nd Sep 2022
Investors are optimistic about Haemonetics' (HAE) better-than-expected results and strong Plasma sales.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
01:50pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Haemonetics (HAE) Inks Epic Deal to Expand Hospital Business
03:35pm, Tuesday, 30'th Aug 2022 Zacks Investment Research
According to Haemonetics (HAE), amid the complex situation of blood supply and staffing shortages, the SafeTrace Tx transfusion management system is set to provide more transfusion safety and efficien
Haemonetics (HAE) Inks Epic Deal to Expand Hospital Business
12:47pm, Tuesday, 30'th Aug 2022
According to Haemonetics (HAE), amid the complex situation of blood supply and staffing shortages, the SafeTrace Tx transfusion management system is set to provide more transfusion safety and efficien
Lantheus Holdings, Inc. (LNTH) Soars to 52-Week High, Time to Cash Out?
01:15pm, Friday, 26'th Aug 2022 Zacks Investment Research
Lantheus Holdings (LNTH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Haemonetics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
06:06pm, Tuesday, 23'rd Aug 2022
BOSTON , Aug. 23, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on
Here's Why Haemonetics (HAE) is a Strong Growth Stock
01:45pm, Friday, 19'th Aug 2022 Zacks Investment Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Haemonetics (HAE) Hits 52-Week High: What's Aiding the Stock?
01:38pm, Friday, 19'th Aug 2022 Zacks Investment Research
Investors are optimistic about Haemonetics' (HAE) potential in its Plasma franchise.
